Skip to content

Nutritional Risk for Hospitalized Patients With Neurology Disorders in China

Nutritional Risk and Health Research for Hospitalized Patients With Neurology Disorders in China

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06510712
Enrollment
10000
Registered
2024-07-19
Start date
2024-09-01
Completion date
2026-06-30
Last updated
2024-07-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurological Disorder

Keywords

nutrition, the risk of malnutrition

Brief summary

Neurology disorders are one of the major public health problems that seriously threaten human health. It often accompanied by various nutritional problems, which can aggravate the primary disease, lead to serious complications, prolong the hospitalization, lead to poor prognosis, and increase family and social economic burdens. According to the previous studies, the risk of malnutrition was approximately 58.5% of stroke patients, and 6% had moderate to severe malnutrition in China. Another study conducted in Beijing showed that the risk of malnutrition of elderly patients in the department of neurology was significantly higher than in other departments (28.5% vs. 26.4%). Strengthening nutritional supervision of patients with neurology disorders will benefit to improve patients' prognosis. Therefore, the aim of this study is to investigate the nutritional status of inpatients with neurology disorders in China, evaluate the impact of different nutritional status on patients' health outcomes, and establish a high-quality, standardized nutrition and health cohort database for neurology disorders.

Interventions

None listed

Sponsors

Xuanwu Hospital, Beijing
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age ≥ 18 years; 2. The primary diagnosis was neurological disorders; 3. Written informed consent.

Exclusion criteria

1. Life expectancy is \< 3 months; 2. Researchers think other ineligible participant for the study.

Design outcomes

Primary

MeasureTime frameDescription
All-cause mortality30 daysMortality defined as all-cause mortality from inclusion to day 30

Secondary

MeasureTime frameDescription
ICU admission30 daysICU admission defined as admission to the intensive care unit from the medical ward from inclusion to day 30
Non-elective hospital readmission30 daysNon-elective hospital readmission defined as non-scheduled hospital readmission after discharge from the index hospital stay to day 30
Decline in functional status of 10% or more30 daysdecline in functional status of 10% or more from admission to day 30 measured by the Barthel's index.
length of in hospital days30 daysTotal length of in hospital days 30 days
Major complications30 daysMajor complications defined as the following complications occurring from inclusion (i.e., not present at the time of inclusion) to day 30 I. Adjudicated nosocomial infection or abscess requiring antibiotic treatment II. respiratory failure with need for invasive or non-invasive ventilation III. major cardiovascular events including stroke, intracranial bleeding, cardiac arrest, myocardial infarction with and without invasive procedure and pulmonary embolism IV. acute renal failure (defined by 2x increase of baseline creatinine or new requirement of dialysis do to volume overload or electrolyte disturbance) V. gastro-intestinal events (hemorrhage, intestinal perforation)

Other

MeasureTime frameDescription
Adverse events30 daysEach of the adverse events

Contacts

Primary ContactGaoting Ma, PhD
demo_doctor@163.com18301579891

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026